PT98921A - Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico - Google Patents

Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico Download PDF

Info

Publication number
PT98921A
PT98921A PT98921A PT9892191A PT98921A PT 98921 A PT98921 A PT 98921A PT 98921 A PT98921 A PT 98921A PT 9892191 A PT9892191 A PT 9892191A PT 98921 A PT98921 A PT 98921A
Authority
PT
Portugal
Prior art keywords
carbon atoms
symptoms
added
pharmaceutically acceptable
quot
Prior art date
Application number
PT98921A
Other languages
English (en)
Portuguese (pt)
Inventor
James Vincent Sorrentino
Donald Kay Riker
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of PT98921A publication Critical patent/PT98921A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98921A 1990-09-11 1991-09-10 Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico PT98921A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58072990A 1990-09-11 1990-09-11

Publications (1)

Publication Number Publication Date
PT98921A true PT98921A (pt) 1992-07-31

Family

ID=24322297

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98921A PT98921A (pt) 1990-09-11 1991-09-10 Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico

Country Status (7)

Country Link
AU (1) AU8505991A (fr)
EG (1) EG19841A (fr)
IE (1) IE913184A1 (fr)
MA (1) MA22278A1 (fr)
MX (1) MX9101031A (fr)
PT (1) PT98921A (fr)
WO (1) WO1992004022A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255639B (it) * 1992-07-30 1995-11-09 Uso dell'oxatomide come agente antitosse
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
JP2002523358A (ja) * 1998-08-25 2002-07-30 プラット,クリス ナプロキセンおよびプソイドエフェドリンを含む徐法性錠剤
US7863287B2 (en) 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US20050192355A1 (en) * 2004-02-17 2005-09-01 Wyeth Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
CA3001337C (fr) * 2015-10-09 2023-12-12 Reckitt Benckiser Llc Formulation pharmaceutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7503081A (nl) * 1974-03-21 1975-09-23 Hoechst Ag Werkwijze voor het bereiden van een gemengde katalysator.
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
EG19841A (en) 1996-03-31
MA22278A1 (fr) 1992-04-01
WO1992004022A1 (fr) 1992-03-19
IE913184A1 (en) 1992-03-11
AU8505991A (en) 1992-03-30
MX9101031A (es) 1992-05-04

Similar Documents

Publication Publication Date Title
WO1995007103A1 (fr) Compositions contenant un sel d'acide amine d'un agent anti-inflammatoire non steroidien a base d'acide propionique et au moins un decongestionnant ou un expectorant ou un antihistaminique ou un antitussif
CA2146637C (fr) Compositions pharmaceutiques et methodes pour traiter les symptomes du rhume
CA2247500A1 (fr) Utilisation de la cafeine et de la clemastine pour le traitement de troubles respiratoires
JP2018135372A (ja) ロキソプロフェン又はその塩含有の医薬組成物<3>
JP5542309B2 (ja) 経口医薬組成物
CA2304005A1 (fr) Compositions et procedes de traitement de troubles respiratoires
PT98921A (pt) Metodo de tratamento de perturbacoes respiratorias em seres humanos ou animais, mediante a administracao de uma composicao compreendendo um derivado de naftaleno especifico
US20020169212A1 (en) Ketoprofen powder for oral use
WO1995007079A1 (fr) Compositions contenant un sel d'acide amine d'agents anti-inflammatoires non steroidiens a base d'acide propionique et de la cafeine
WO1994014476A1 (fr) Utilisation d'antipodes s(+) d'agents analgesiques dans la fabrication d'une composition de traitement de troubles respiratoires
JP5952944B2 (ja) ロキソプロフェン又はその塩含有の医薬組成物そのii
JP5232520B2 (ja) ロキソプロフェンを含有する抗アデノウイルス剤
JP2008115168A (ja) 抗アデノウイルス剤
JP5993498B2 (ja) ロキソプロフェン又はその塩を含有する医薬組成物その弐
JP2017132819A (ja) ロキソプロフェン又はその塩含有の医薬組成物
CA2090234C (fr) Methode permettant d'obtenir un effet analgesique ameliore
AU5899394A (en) Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen
CA2017923A1 (fr) Composes d'antitussifs pour administration orale
JP5898964B2 (ja) ロキソプロフェン又はその塩を含有する医薬組成物
JP2008285474A (ja) 抗アデノウイルス剤を含有する医薬組成物
US20060147481A1 (en) Ketoprofen powder for oral use
JP2016027022A (ja) 医薬組成物

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920330

FC3A Refusal

Effective date: 19981109